PARATUS acquires projodis
PARATUS expands its LIS offering, acquiring projodis, Germany’s leading provider of laboratory software solutions in human genetics
Munich, Germany, September 9, 2024. GREENPEAK Partners announced today that through their group PARATUS, they have acquired projodis, the leading provider of laboratory information system (LIS) solutions servicing human geneticists in Germany with further presence in Austria and Switzerland. The acquisition is another strategic building block for PARATUS in its mission to become a leading global provider of best-of-breed healthcare IT solutions, focussing on diagnostics, that empower medical service professionals and improve patient care.
The decision to acquire projodis was influenced by their strong market position in human genetics and strategic fit within PARATUS’ growing group. “The projodis product portfolio is a perfect complement to that of DB Soft, our LIS provider in Spain,” said Friedrich von Kleist, CEO of PARATUS.
“Adding them to our group and aligning them with DB Soft enables us to build a strong LIS Cluster, which significantly advances our LIS technology and portfolio and supports the expansion into new markets while strengthening the whole PARATUS group.”
In line with PARATUS’ business strategy, projodis will retain its individual operations and brand identity, emphasizing PARATUS’ commitment to collaboration without losing the renowned market presence of its acquired companies. projodis products and services will continue without disruption in access or customer support
“I’m thrilled we’ve found a strong partner to take the next step in our company’s development,” said Oliver Krause, Founder and Managing Director of projodis. “A driving factor in our decision to join the group was having, through prior work, already experienced the truly collaborative culture of PARATUS.” Krause added, “I’m confident that together we can grow faster, accelerate innovation, and deliver even better services to our clients.”
PARATUS’ robust support for its group companies encompasses financial investment, collaborative tendering, and access to shared resources in areas such as finance, marketing, sales, quality management, new market entry, and more.
Meda Contact: For more information or to schedule an interview, please contact:
Mr. Friedrich von Kleist, CEO of PARATUS: fkleist@paratus-group.com
ABOUT PARATUS
PARATUS was formed in 2021 with the goal of creating a global group of best-of-breed healthcare IT companies with a strong position in diagnostics that collaborates to deliver state-of-the-art, tailored solutions to medical service providers that improve healthcare services and patient care, boost productivity, and reduce costs. PARATUS is a group of like-minded market leaders that foster growth through collaboration, sharing best practices, and shared services in finance, HR, regulatory, IT security, and more. Headquartered in Munich, Germany, PARATUS is pursuing a long-term growth path, both organically and by adding new partners to its group. Learn more at www.paratus-group.com
ABOUT projodis
projodis GmbH is the German market leader in advanced laboratory software solutions, specializing in the development and implementation of cutting-edge tools for the management, control, and monitoring of human genetic laboratory processes and consultations. Based in Butzbach, Germany, and founded in 2010, projodis serves the majority of the human genetic departments of university hospitals and leading outpatient genetic laboratories due to a clear focus and understanding of the unique needs of the genetic field. www.projodis.net
ABOUT GREENPEAK PARTNERS
GREENPEAK Partners is a company builder with a proven track record and comprehensive expertise in the foundation, development, and expansion of industry leaders. While executing its Buy Build strategies, GREENPEAK aims to develop industry leaders by virtue of strong partnerships, ESG values, and aligned sustainable interests. To date, the GREENPEAK Partners team has built over ten platforms, with annual revenues exceeding €1 billion. www.greenpeak-partners.com
